Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Sclerosing cholangitis (SC) represents a spectrum of chronic progressive cholestatic diseases of the intrahepatic and/or extrahepatic biliary system characterized by patchy inflammation, fibrosis, and stricturing. Primary and secondary SC must be distinguished given the different treatment modalities, risks of malignancy, and progression to portal hypertension, cirrhosis, and hepatic failure. This review focuses on secondary SC and the pathogenic mechanisms, risk factors, clinical presentation, and novel imaging modalities that help to distinguish between these conditions. We explore the detailed use of cholangiography and ultrasound imaging techniques.

More information Original publication

DOI

10.4103/eus-d-22-00208

Type

Journal article

Publication Date

2023-03-01T00:00:00+00:00

Volume

12

Pages

181 - 199

Total pages

18

Addresses

M, e, d, i, c, a, l, , D, e, p, a, r, t, m, e, n, t, , I, /, G, a, s, t, r, o, e, n, t, e, r, o, l, o, g, y, ,, , S, a, n, a, , H, o, s, p, i, t, a, l, , L, i, c, h, t, e, n, b, e, r, g, ,, , B, e, r, l, i, n, ,, , G, e, r, m, a, n, y, .